Marie-Andrée will be responsible for the Project Management team, the Logistics team and the Packaging team.
For its ABE-Liver trial on its lead candidate ezurpimtrostat (GNS561), COLCA MS has committed to GENOSCIENCE for product packaging, certification and distribution to clinical trial centers.
COLCA MS is proud to support Enterome, a clinical-stage biotechnology company developing novel, ready-to-use immunotherapies capable of targeting solid, liquid or metastatic tumors in a broad patient population.
COLCA MEDICAL & SCIENTIFIC is pleased to announce that it has joined the PETRONE GROUP, a privately held Italian family-owned group specializing in pharmaceutical distribution, composed of 30 companies and headquartered in Naples.
COLCA MS supports and accompanies SQY THERAPEUTICS in its fight against Duchenne Muscular Dystrophy (DMD), a genetic disease that causes a progressive degeneration of the body’s muscles.
Concerned about offering personalized, quality and environmentally friendly services, COLCA Medical & Scientific renews its confidence in EMBALL’ISO for the supply of very high performance isothermal packaging solutions.
COLCA MS is a leading partner in the supply of ATX01. COLCA MS manages importation of Drug Product imports to France, performs randomized packaging and labeling services, and ensures the distribution of IMPs* to clinical investigator centers in the European Union and the United States.
IMAXIO relies on the expertise in pharmaceutical packaging and the supply agility of COLCA MS to distribute its Spirolept vaccine in compliance with GMP and GDP Good Practices.
COLCA MS, provides on behalf of OSIVAX for all the secondary clinical packaging as well as the distribution in the European Union and Australia regarding temperature controlled.
COLCA MS carries out storage, packaging and batch certification activities on behalf of the biotechnology company based to the east of Lyon. ADVANCED BIODESIGN benefits from our expertise.
BIOSE INDUSTRIE uses the full range of COLCA MS expertise to distribute R&D products and clinical tests throughout Europe, the U.S., Australia and South Korea.
COLCA MS joins the French CROs Association and will attend the Clinical Research Day to be held at the Paris Etoile HYATT Regency on Jan. 27, 2022.
